港股異動 | 次新股森松國際(2155.HK)續升超12%破頂 較招股價已大漲5.7倍
格隆匯7月6日丨森松國際(2155.HK)繼續拉昇上揚,現漲超12%,高見14.16港元再度刷新歷史高價,總市值超140億港元。該股於6月28日上市,較招股價2.48港元已大漲5.7倍。分析人士指出,森松國際基本面較為優質,且符合國家經濟轉型大趨勢以及技術壁壘構築起長期價值,另一方面跟公司IPO發行估值相對較低有關。 森松國際是中國最大的非國有壓力設備製造商,此次上市成功摘得港股壓力設備第一股的頭銜。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.